1. Home
  2. ASTH vs EVO Comparison

ASTH vs EVO Comparison

Compare ASTH & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Astrana Health Inc.

ASTH

Astrana Health Inc.

HOLD

Current Price

$25.41

Market Cap

1.2B

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$3.11

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASTH
EVO
Founded
1994
1993
Country
United States
Germany
Employees
N/A
4766
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.1B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
ASTH
EVO
Price
$25.41
$3.11
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
1
Target Price
$41.33
$7.00
AVG Volume (30 Days)
531.7K
259.6K
Earning Date
11-06-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.20
N/A
Revenue
$2,896,452,000.00
$887,396,457.00
Revenue This Year
$58.46
N/A
Revenue Next Year
$25.59
$8.52
P/E Ratio
$128.58
N/A
Revenue Growth
68.17
N/A
52 Week Low
$20.12
$2.84
52 Week High
$39.97
$5.10

Technical Indicators

Market Signals
Indicator
ASTH
EVO
Relative Strength Index (RSI) 59.04 50.32
Support Level $21.98 $3.03
Resistance Level $25.48 $3.05
Average True Range (ATR) 0.99 0.09
MACD 0.57 0.03
Stochastic Oscillator 97.11 80.42

Price Performance

Historical Comparison
ASTH
EVO

About ASTH Astrana Health Inc.

Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. The company's three reportable segments are Care Partners, Care Delivery, and Care Enablement. It generates the majority of its revenue from the Care Partners segment.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: